BioIntelliSense, Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
through Jun 4, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Differences between reported disclosures
Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.
| Field | Dec 19, 2025 · D | Jun 4, 2026 · D/A | Later minus earlier |
|---|---|---|---|
| Reported offering amount | $58,350,027 | $58,350,027 | $0 |
| Reported amount sold | $58,050,027 | $58,349,365 | $299,338 |
| Reported investor count | — | 14 | — |
| Reported minimum investment | $0 | $0 | $0 |
Earlier SEC source: 0001824134-25-000003 · Later SEC source: 0001824134-26-000001
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $58,350,027
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $58,349,365
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Filings by year
- 20251 filing
- 20261 filing
Submission counts, including amendments; not dollars raised or distinct funding rounds.
Form D filings (2)
-
0001824134-26-000001D/A · Jun 4, 2026 · OtherOffering: $58,350,027Sold: $58,349,365
Compared with 0001824134-25-000003:
- Reported amount sold: $58,050,027 → $58,349,365
- Reported investor count: Unavailable → 14
-
0001824134-25-000003D · Dec 19, 2025 · OtherOffering: $58,350,027Sold: $58,050,027